$0.360
-0.015 (-4.05%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
PMCB Prediction & Forecast by Similar Chart Analysis
Alphio's PMCB stock price prediction model matches the current PharmaCyte Biotech Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.36 (+0.05%). The 1-week path is $0.39 (+7.13%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy PharmaCyte Biotech Inc Stock?
PharmaCyte Biotech Inc (PMCB) appears to be a good buy right now due to its recent price performance and favorable technical indicators. The current price is $0.36, which is near the 52-week low of $0.30, indicating potential for upside as it has a 52-week high of $1.51. The stock has shown a 5-day change of +19.17%, suggesting a positive short-term momentum. Additionally, the forward P/E ratio is 7.02, indicating that the stock may be undervalued relative to its future earnings potential. However, a significant risk is the negative net income reported for the last quarter at -$4,873,411, which reflects ongoing financial challenges. Overall, the combination of a low entry price, potential for recovery, and positive short-term trends supports a buy recommendation.
PMCB stock price ended at $0.36 on Friday, after losing -4.05%
PharmaCyte Biotech Inc (PMCB) last closed at $0.36, losing -4.05%. These facts feed the 1-day and 1-week PMCB price prediction above.
Forecast Drivers
PharmaCyte Biotech Inc (PMCB) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches PMCB, ranked by similarity.
Seasonality analysis for PMCB
Historically the probability of a positive November return for PMCB is 0.00%. January offers the highest probability of a positive month at 60.66%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for PMCB
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Nov 2026 | $1.07 | $1.07 | $1.11 | +197.77% |
| Dec 2026 | $0.86 | $0.95 | $0.97 | +162.59% |
In 2026, PharmaCyte Biotech Inc (PMCB) is projected to range from $0.86 to $1.11.
PharmaCyte Biotech Inc 2026 monthly forecast
In Nov 2026, PharmaCyte Biotech Inc is projected to average $1.07, with a low of $1.07 and high of $1.11.
In Dec 2026, PharmaCyte Biotech Inc is projected to average $0.95, with a low of $0.86 and high of $0.97.
Related articles
- CPI Report and the Stock Market: How to Read October 2026 Inflation Data Before the Fed DecidesOctober 2026 CPI lands Nov 10 with no year-over-year number and Fed hike odds near 80%. Learn how to read CPI, which stocks react, and how to plan for it.
- Are You Buying NVIDIA’s Earnings or Its CEO’s Perfect Image?An Alphio analysis of NVIDIA’s share-price timeline, operating results, governance uncertainty and upcoming earnings.
- Stock Market After the 2026 Midterms: What a Democratic Congress Means for InvestorsDemocrats swept Congress in the 2026 midterms. See how stocks reacted, what history says about post-midterm returns, and which sectors face new risks.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.